Clinical Study
Dysregulation of Vascular Endothelial Progenitor Cells Lung-Homing in Subjects with COPD
Table 1
Subject characteristics of COPD patients and normal subjects.
| Characteristic | COPD patients () | Normal subjects () |
| Age, years | | 31.3 ± 4.5 | Gender, % male | 85.7 | 42.9 | BMI, kg⋅m2 | 26.7 ± 4.6 | 27.2 ± 5.2 | Smoking status | | | Current, % | 66.7 | 0.0 | Ex-smoker, % | 33.3 | 16.7 | Nonsmoker, % | 0.0 | 83.3 | Cigarette pack-years | 60.6 ± 22.3 | 1.3 ± 2.2 | Comorbidities | | | Hypertension, % | 25.0 | 0.0 | Hyperlipidemia, % | 25.0 | 0.0 | Statin use, % | 16.7 | 0.0 | Pulmonary function | | | FEV1 Prebronchodilator, % predicted | 40.4 ± 20.1 | 101.8 ± 15.2 | FEV1 Postbronchodilator, % predicted | 47.6 ± 11.5 | 109.0 ± 14.1 | FVC Prebronchodilator, % predicted | 56.4 ± 13.8 | 114.6 ± 15.2 | FVC Postbronchodilator, % predicted | 0.65 ± 0.1 | 0.88 ± 0.0 | FEV1/FVC | 0.61 ± 0.07 | 0.85 ± 0.03 |
|
|
Values are expressed as mean ± SD. Significant difference () between groups.
|